{"entity":{"type":"insider","cik":"0001266567","url":"/insider/0001266567","json_url":"/insider/0001266567.json","name":"ATWOOD BRIAN G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":188,"n_filings":29,"first":"2004-05-25","last":"2016-06-10","span_basis":"filed_date"},"name_variants":[{"name":"ATWOOD BRIAN G","source":"filing","n_filings":29,"first_seen":"2004-05-25","last_seen":"2016-06-10"}],"transactions":[{"id":2650541,"accession":"0001104659-16-126659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-126659","line_url":"/filing/0001104659-16-126659","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ATWOOD BRIAN G; ROBERTSON REBECCA B; COLELLA SAMUEL D; Versant Venture Capital III, L.P.; LINK WILLIAM J PHD; Versant Ventures III, LLC; JAFFE ROSS A MD; Versant Side Fund III, L.P.; MILDER DONALD B; Versant Development Fund III, L.P.","owner_display_name":"ATWOOD BRIAN G","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":714285.0,"shares_display":"714,285","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":3511670.0,"shares_owned_after_display":"3,511,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-08","filed_date":"2016-06-10","scope":"insider","n_lines":2},{"id":3174262,"accession":"0001209191-16-125335","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-16-125335","line_url":"/filing/0001209191-16-125335","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"GLAUKOS Corp","issuer_ticker":"GKOS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"VERSANT VENTURE CAPITAL I LP; VERSANT AFFILIATES FUND I-B LP; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G; VERSANT AFFILIATES FUND I-A LP; VERSANT SIDE FUND I LP; VERSANT VENTURES I LLC; COLELLA SAMUEL D; MILDER DONALD B","owner_display_name":"VERSANT VENTURE CAPITAL I LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34058.0,"shares_display":"34,058","price_per_share":23.98,"price_display":"23.98","price_state":"stated","total_value":816710.84,"total_display":"816,710.84","total_whole":"816,711","shares_owned_after":109395.0,"shares_owned_after_display":"109,395","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider","n_lines":2},{"id":3184598,"accession":"0001144204-16-104556","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-16-104556","line_url":"/filing/0001144204-16-104556","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.; LUBASH BARBARA N; Versant Ventures III, LLC; MILDER DONALD B; Praeger Robin L.; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G","owner_display_name":"Versant Venture Capital III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":258044.0,"shares_display":"258,044","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":2580.44,"total_display":"2,580.44","total_whole":"2,580","shares_owned_after":1334617.0,"shares_owned_after_display":"1,334,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider","n_lines":4},{"id":3184584,"accession":"0001144204-16-104556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-104556","line_url":"/filing/0001144204-16-104556","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.; LUBASH BARBARA N; Versant Ventures III, LLC; MILDER DONALD B; Praeger Robin L.; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G","owner_display_name":"Versant Venture Capital III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":1931094.0,"shares_owned_after_display":"1,931,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider","n_lines":2},{"id":2172863,"accession":"0001144204-16-104561","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-16-104561","line_url":"/filing/0001144204-16-104561","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Bolzon Bradley J PhD; Warden Charles M; ATWOOD BRIAN G","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":258044.0,"shares_display":"258,044","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":2580.44,"total_display":"2,580.44","total_whole":"2,580","shares_owned_after":1334617.0,"shares_owned_after_display":"1,334,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider","n_lines":4},{"id":2172844,"accession":"0001144204-16-104561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-104561","line_url":"/filing/0001144204-16-104561","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Bolzon Bradley J PhD; Warden Charles M; ATWOOD BRIAN G","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":1931094.0,"shares_owned_after_display":"1,931,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider","n_lines":2},{"id":8250844,"accession":"0001140361-15-019184","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-15-019184","line_url":"/filing/0001140361-15-019184#line-4","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"OPGEN INC","issuer_ticker":"OPGNOPGNW","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":413332.0,"shares_display":"413,332","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2479992.0,"total_display":"2,479,992.00","total_whole":"2,479,992","shares_owned_after":485925.0,"shares_owned_after_display":"485,925","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-08","filed_date":"2015-05-12","scope":"insider"},{"id":6808273,"accession":"0001209191-14-070178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-070178","line_url":"/filing/0001209191-14-070178#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Side Fund II, LP; JAFFE ROSS A MD; COLELLA SAMUEL D; MILDER DONALD B; LINK WILLIAM J PHD; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; ROBERTSON REBECCA B; ATWOOD BRIAN G; Versant Ventures II LLC","owner_display_name":"Versant Side Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5343.0,"shares_display":"5,343","price_per_share":24.8852,"price_display":"24.89","price_state":"stated","total_value":132961.6236,"total_display":"132,961.62","total_whole":"132,962","shares_owned_after":40569.0,"shares_owned_after_display":"40,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-19","scope":"insider"},{"id":7035664,"accession":"0001209191-14-069010","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-14-069010","line_url":"/filing/0001209191-14-069010#line-16","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"JAFFE ROSS A MD; Versant Ventures II LLC; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; ROBERTSON REBECCA B; MILDER DONALD B; Versant Side Fund II, LP; ATWOOD BRIAN G; LINK WILLIAM J PHD; COLELLA SAMUEL D","owner_display_name":"JAFFE ROSS A MD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3928.0,"shares_display":"3,928","price_per_share":25.0627,"price_display":"25.06","price_state":"stated","total_value":98446.2856,"total_display":"98,446.29","total_whole":"98,446","shares_owned_after":45912.0,"shares_owned_after_display":"45,912","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-14","scope":"insider"},{"id":7035661,"accession":"0001209191-14-069010","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-14-069010","line_url":"/filing/0001209191-14-069010#line-15","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"JAFFE ROSS A MD; Versant Ventures II LLC; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; ROBERTSON REBECCA B; MILDER DONALD B; Versant Side Fund II, LP; ATWOOD BRIAN G; LINK WILLIAM J PHD; COLELLA SAMUEL D","owner_display_name":"JAFFE ROSS A MD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5505.0,"shares_display":"5,505","price_per_share":25.1814,"price_display":"25.18","price_state":"stated","total_value":138623.607,"total_display":"138,623.61","total_whole":"138,624","shares_owned_after":49840.0,"shares_owned_after_display":"49,840","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-14","scope":"insider"},{"id":6652965,"accession":"0001209191-14-067956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-067956","line_url":"/filing/0001209191-14-067956#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"JAFFE ROSS A MD; ATWOOD BRIAN G; ROBERTSON REBECCA B; COLELLA SAMUEL D; Versant Ventures II LLC; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LINK WILLIAM J PHD; MILDER DONALD B; Versant Side Fund II, LP","owner_display_name":"JAFFE ROSS A MD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2992.0,"shares_display":"2,992","price_per_share":24.4201,"price_display":"24.42","price_state":"stated","total_value":73064.9392,"total_display":"73,064.94","total_whole":"73,065","shares_owned_after":12188.0,"shares_owned_after_display":"12,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-10","filed_date":"2014-11-12","scope":"insider"},{"id":9269604,"accession":"0001209191-15-040942","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-040942","line_url":"/filing/0001209191-15-040942#line-2","is_derivative":false,"issuer_cik":"0001228684","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001228684","owner_cik":null,"owner_name":"ATWOOD BRIAN G; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; MILDER DONALD B; Versant Affiliates Fund II-A, LP; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Ventures II LLC","owner_display_name":"ATWOOD BRIAN G","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3150.0,"shares_display":"3,150","price_per_share":23.9499,"price_display":"23.95","price_state":"stated","total_value":75442.185,"total_display":"75,442.18","total_whole":"75,442","shares_owned_after":55345.0,"shares_owned_after_display":"55,345","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-07","filed_date":"2015-05-11","scope":"insider"},{"id":6355671,"accession":"0001209191-14-067469","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-14-067469","line_url":"/filing/0001209191-14-067469#line-13","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ATWOOD BRIAN G; LINK WILLIAM J PHD; ROBERTSON REBECCA B; Versant Ventures II LLC; MILDER DONALD B; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; JAFFE ROSS A MD; COLELLA SAMUEL D","owner_display_name":"ATWOOD BRIAN G","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3150.0,"shares_display":"3,150","price_per_share":23.9499,"price_display":"23.95","price_state":"stated","total_value":75442.185,"total_display":"75,442.18","total_whole":"75,442","shares_owned_after":55345.0,"shares_owned_after_display":"55,345","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-07","filed_date":"2014-11-07","scope":"insider"},{"id":9269603,"accession":"0001209191-15-040942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-040942","line_url":"/filing/0001209191-15-040942#line-1","is_derivative":false,"issuer_cik":"0001228684","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001228684","owner_cik":null,"owner_name":"ATWOOD BRIAN G; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; MILDER DONALD B; Versant Affiliates Fund II-A, LP; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Ventures II LLC","owner_display_name":"ATWOOD BRIAN G","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4238.0,"shares_display":"4,238","price_per_share":24.5617,"price_display":"24.56","price_state":"stated","total_value":104092.4846,"total_display":"104,092.48","total_whole":"104,092","shares_owned_after":58495.0,"shares_owned_after_display":"58,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-06","filed_date":"2015-05-11","scope":"insider"},{"id":6355668,"accession":"0001209191-14-067469","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-14-067469","line_url":"/filing/0001209191-14-067469#line-12","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ATWOOD BRIAN G; LINK WILLIAM J PHD; ROBERTSON REBECCA B; Versant Ventures II LLC; MILDER DONALD B; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; JAFFE ROSS A MD; COLELLA SAMUEL D","owner_display_name":"ATWOOD BRIAN G","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4238.0,"shares_display":"4,238","price_per_share":24.5617,"price_display":"24.56","price_state":"stated","total_value":104092.4846,"total_display":"104,092.48","total_whole":"104,092","shares_owned_after":58495.0,"shares_owned_after_display":"58,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-06","filed_date":"2014-11-07","scope":"insider"},{"id":6976804,"accession":"0001209191-14-065135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-065135","line_url":"/filing/0001209191-14-065135#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LINK WILLIAM J PHD; Versant Ventures II LLC; Versant Side Fund II, LP; COLELLA SAMUEL D; ROBERTSON REBECCA B; JAFFE ROSS A MD; MILDER DONALD B; ATWOOD BRIAN G","owner_display_name":"Versant Venture Capital II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4647.0,"shares_display":"4,647","price_per_share":20.7565,"price_display":"20.76","price_state":"stated","total_value":96455.4555,"total_display":"96,455.46","total_whole":"96,455","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-24","filed_date":"2014-10-28","scope":"insider"},{"id":6593472,"accession":"0001209191-14-063155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-063155","line_url":"/filing/0001209191-14-063155","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; COLELLA SAMUEL D; Versant Side Fund II, LP; LINK WILLIAM J PHD; Versant Ventures II LLC; JAFFE ROSS A MD; LUBASH BARBARA N; ATWOOD BRIAN G; MILDER DONALD B","owner_display_name":"Versant Venture Capital II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":20.8255,"price_display":"20.83","price_state":"stated","total_value":39568.45,"total_display":"39,568.45","total_whole":"39,568","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-09","filed_date":"2014-10-14","scope":"insider","n_lines":2},{"id":7096850,"accession":"0001209191-14-062716","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-14-062716","line_url":"/filing/0001209191-14-062716","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ATWOOD BRIAN G; COLELLA SAMUEL D; JAFFE ROSS A MD; MILDER DONALD B; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LINK WILLIAM J PHD; LUBASH BARBARA N; Versant Side Fund II, LP; Versant Ventures II LLC","owner_display_name":"ATWOOD BRIAN G","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6907.0,"shares_display":"6,907","price_per_share":21.0266,"price_display":"21.03","price_state":"stated","total_value":145230.7262,"total_display":"145,230.73","total_whole":"145,231","shares_owned_after":1756.0,"shares_owned_after_display":"1,756","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-09","scope":"insider","n_lines":2},{"id":6913782,"accession":"0001209191-14-057611","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-14-057611","line_url":"/filing/0001209191-14-057611#line-9","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ATWOOD BRIAN G; JAFFE ROSS A MD; Versant Ventures II LLC; LINK WILLIAM J PHD; Versant Side Fund II, LP; MILDER DONALD B; LUBASH BARBARA N; COLELLA SAMUEL D; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP","owner_display_name":"ATWOOD BRIAN G","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7388.0,"shares_display":"7,388","price_per_share":23.2496,"price_display":"23.25","price_state":"stated","total_value":171768.0448,"total_display":"171,768.04","total_whole":"171,768","shares_owned_after":62733.0,"shares_owned_after_display":"62,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-09","filed_date":"2014-09-12","scope":"insider"},{"id":6183417,"accession":"0001123292-14-000779","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001123292-14-000779","line_url":"/filing/0001123292-14-000779#line-6","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":208334.0,"shares_display":"208,334","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2500008.0,"total_display":"2,500,008.00","total_whole":"2,500,008","shares_owned_after":1974877.0,"shares_owned_after_display":"1,974,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-29","filed_date":"2014-07-31","scope":"insider"},{"id":6183414,"accession":"0001123292-14-000779","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001123292-14-000779","line_url":"/filing/0001123292-14-000779#line-5","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":233333.0,"shares_display":"233,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2799996.0,"total_display":"2,799,996.00","total_whole":"2,799,996","shares_owned_after":2208210.0,"shares_owned_after_display":"2,208,210","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-29","filed_date":"2014-07-31","scope":"insider"},{"id":5406468,"accession":"0001123292-13-001403","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-13-001403","line_url":"/filing/0001123292-13-001403#line-3","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76923.0,"shares_display":"76,923","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":1092152.0,"shares_owned_after_display":"1,092,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-23","filed_date":"2013-09-24","scope":"insider"},{"id":8963132,"accession":"0001104659-11-064968","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-11-064968","line_url":"/filing/0001104659-11-064968#line-2","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":661323.0,"shares_display":"661,323","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":2159289.0,"shares_owned_after_display":"2,159,289","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-16","filed_date":"2011-11-17","scope":"insider"},{"id":8963131,"accession":"0001104659-11-064968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-11-064968","line_url":"/filing/0001104659-11-064968#line-1","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4165.0,"shares_display":"4,165","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":13600.0,"shares_owned_after_display":"13,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-16","filed_date":"2011-11-17","scope":"insider"},{"id":7744072,"accession":"0001181431-10-041152","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-041152","line_url":"/filing/0001181431-10-041152#line-3","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":914529.0,"shares_display":"914,529","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":4572645.0,"total_display":"4,572,645.00","total_whole":"4,572,645","shares_owned_after":3235839.0,"shares_owned_after_display":"3,235,839","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-06","filed_date":"2010-08-10","scope":"insider"},{"id":5769427,"accession":"0001209191-09-045156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-045156","line_url":"/filing/0001209191-09-045156#line-1","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":242931.0,"shares_display":"242,931","price_per_share":2.5728,"price_display":"2.57","price_state":"stated","total_value":625012.8768,"total_display":"625,012.88","total_whole":"625,013","shares_owned_after":10709818.0,"shares_owned_after_display":"10,709,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-21","scope":"insider"},{"id":3568553,"accession":"0001209191-08-067536","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-067536","line_url":"/filing/0001209191-08-067536#line-3","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8386581.0,"shares_display":"8,386,581","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":10466887.0,"shares_owned_after_display":"10,466,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":3568551,"accession":"0001209191-08-067536","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-067536","line_url":"/filing/0001209191-08-067536#line-2","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":159154.0,"shares_display":"159,154","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":196522.0,"shares_owned_after_display":"196,522","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":3568549,"accession":"0001209191-08-067536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-067536","line_url":"/filing/0001209191-08-067536#line-1","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74955.0,"shares_display":"74,955","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":92533.0,"shares_owned_after_display":"92,533","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":8507748,"accession":"0001209191-07-034580","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-034580","line_url":"/filing/0001209191-07-034580#line-4","is_derivative":false,"issuer_cik":"0001266567","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001266567","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":111111.0,"shares_display":"111,111","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":111111.0,"shares_owned_after_display":"111,111","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-30","filed_date":"2007-06-01","scope":"insider"},{"id":3772930,"accession":"0001181431-06-030242","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-06-030242","line_url":"/filing/0001181431-06-030242#line-6","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"NOVACEA INC","issuer_ticker":"NOVC","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":null,"owner_name":"Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LUBASH BARBARA N; MILDER DONALD B; ATWOOD BRIAN G; COLELLA SAMUEL D; Samuels Camille D; Versant Side Fund II, LP; Versant Ventures II LLC; JAFFE ROSS A MD","owner_display_name":"Versant Venture Capital II, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230769.0,"shares_display":"230,769","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2044744.0,"shares_owned_after_display":"2,044,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-15","filed_date":"2006-05-15","scope":"insider"},{"id":481267,"accession":"0001145443-04-000920","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001145443-04-000920","line_url":"/filing/0001145443-04-000920#line-9","is_derivative":false,"issuer_cik":"0001203866","issuer_name":"PHARMION CORP","issuer_ticker":"PHRM","issuer_name_source":null,"issuer_url":"/issuer/0001203866","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":37.45,"price_display":"37.45","price_state":"stated","total_value":37450.0,"total_display":"37,450.00","total_whole":"37,450","shares_owned_after":938194.0,"shares_owned_after_display":"938,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-27","scope":"insider"},{"id":481266,"accession":"0001145443-04-000920","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001145443-04-000920","line_url":"/filing/0001145443-04-000920#line-8","is_derivative":false,"issuer_cik":"0001203866","issuer_name":"PHARMION CORP","issuer_ticker":"PHRM","issuer_name_source":null,"issuer_url":"/issuer/0001203866","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":37.22,"price_display":"37.22","price_state":"stated","total_value":22332.0,"total_display":"22,332.00","total_whole":"22,332","shares_owned_after":940394.0,"shares_owned_after_display":"940,394","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-27","scope":"insider"},{"id":481265,"accession":"0001145443-04-000920","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001145443-04-000920","line_url":"/filing/0001145443-04-000920#line-7","is_derivative":false,"issuer_cik":"0001203866","issuer_name":"PHARMION CORP","issuer_ticker":"PHRM","issuer_name_source":null,"issuer_url":"/issuer/0001203866","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":37.25,"price_display":"37.25","price_state":"stated","total_value":14900.0,"total_display":"14,900.00","total_whole":"14,900","shares_owned_after":939794.0,"shares_owned_after_display":"939,794","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-27","scope":"insider"},{"id":481264,"accession":"0001145443-04-000920","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001145443-04-000920","line_url":"/filing/0001145443-04-000920#line-6","is_derivative":false,"issuer_cik":"0001203866","issuer_name":"PHARMION CORP","issuer_ticker":"PHRM","issuer_name_source":null,"issuer_url":"/issuer/0001203866","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":37.4,"price_display":"37.40","price_state":"stated","total_value":11220.0,"total_display":"11,220.00","total_whole":"11,220","shares_owned_after":939194.0,"shares_owned_after_display":"939,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-27","scope":"insider"},{"id":481263,"accession":"0001145443-04-000920","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001145443-04-000920","line_url":"/filing/0001145443-04-000920#line-5","is_derivative":false,"issuer_cik":"0001203866","issuer_name":"PHARMION CORP","issuer_ticker":"PHRM","issuer_name_source":null,"issuer_url":"/issuer/0001203866","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":37.23,"price_display":"37.23","price_state":"stated","total_value":7446.0,"total_display":"7,446.00","total_whole":"7,446","shares_owned_after":940194.0,"shares_owned_after_display":"940,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-27","scope":"insider"},{"id":481262,"accession":"0001145443-04-000920","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001145443-04-000920","line_url":"/filing/0001145443-04-000920#line-4","is_derivative":false,"issuer_cik":"0001203866","issuer_name":"PHARMION CORP","issuer_ticker":"PHRM","issuer_name_source":null,"issuer_url":"/issuer/0001203866","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":37.34,"price_display":"37.34","price_state":"stated","total_value":3734.0,"total_display":"3,734.00","total_whole":"3,734","shares_owned_after":939494.0,"shares_owned_after_display":"939,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-27","scope":"insider"},{"id":481261,"accession":"0001145443-04-000920","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001145443-04-000920","line_url":"/filing/0001145443-04-000920#line-3","is_derivative":false,"issuer_cik":"0001203866","issuer_name":"PHARMION CORP","issuer_ticker":"PHRM","issuer_name_source":null,"issuer_url":"/issuer/0001203866","owner_cik":"0001266567","owner_name":"ATWOOD BRIAN G","owner_display_name":"ATWOOD BRIAN G","owner_url":"/insider/0001266567","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":37.32,"price_display":"37.32","price_state":"stated","total_value":3732.0,"total_display":"3,732.00","total_whole":"3,732","shares_owned_after":939594.0,"shares_owned_after_display":"939,594","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-27","scope":"insider"}],"collapsed":true,"next_cursor":"2004-05-25|481261","ledger_fault":false,"count":{"value":157,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":146,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":157},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001419600","name":"Flexion Therapeutics Inc","url":"/issuer/0001419600","role":"Ten percent owner","n_filings":1,"first_seen":"2016-06-10","last_seen":"2016-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001192448","name":"GLAUKOS Corp","url":"/issuer/0001192448","role":"Other","n_filings":1,"first_seen":"2016-06-02","last_seen":"2016-06-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001429386","name":"PHASERX, INC.","url":"/issuer/0001429386","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2016-05-24","last_seen":"2016-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001293818","name":"OPGEN INC","url":"/issuer/0001293818","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2015-05-12","last_seen":"2015-05-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001294133","name":"Inogen Inc","url":"/issuer/0001294133","role":"Ten percent owner","n_filings":9,"first_seen":"2014-09-12","last_seen":"2015-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001437786","name":"Immune Design Corp.","url":"/issuer/0001437786","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2014-07-31","last_seen":"2014-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001175505","name":"FIVE PRIME THERAPEUTICS INC","url":"/issuer/0001175505","role":"Director","n_filings":1,"first_seen":"2013-09-24","last_seen":"2013-09-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2011-11-17","last_seen":"2011-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2010-08-10","last_seen":"2010-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2007-06-01","last_seen":"2009-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"NOVACEA INC","url":"/issuer/0001178711","role":"Ten percent owner","n_filings":1,"first_seen":"2006-05-15","last_seen":"2006-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001203866","name":"PHARMION CORP","url":"/issuer/0001203866","role":"Director","n_filings":7,"first_seen":"2004-05-25","last_seen":"2004-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001266567","retrieved_at":"2026-08-24T15:21:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}